Company / SG&A Expense
Liquidia Corp SG&A Expense History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$157.2M
FY2025
5-year range
$23.1M / $157.2M
FY2021-FY2025
Trend
+92.7%
vs FY2024
Sector context
#87 of 211
Health Care
What the data says
At $157M, Liquidia Corp's sg&a expense ranks #125 of 211 in the Health Care sector. SG&A Expense has increased for 4 consecutive years, from $23M in FY2021 to $157M in FY2025.
Based on SEC 10-K filings.
$157M in FY2025 with a 5-year CAGR of +41.8%.
Increased from $45M to $157M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +69.3%
- 5-Year CAGR
- +41.8%
- 10-Year CAGR
- -
Sector benchmark
#125 of 211 in Health CareTop 59% of 211This company $157.2M Sector average $728.7M
▼
-78.4% below sector average
Key checks
Key Insights
- Liquidia Corp's sg&a expense has grown for 4 consecutive years.
- 5-year CAGR of +41.8%, indicating consistent growth.
- In FY2025, sg&a expense increased 92.7% year-over-year.
- Ranks #87 out of 211 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.26 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $157.2M | +92.7% |
| FY2024 | $81.6M | +82.3% |
| FY2023 | $44.7M | +38.0% |
| FY2022 | $32.4M | +40.2% |
| FY2021 | $23.1M | -15.6% |
| FY2020 | $27.4M | +101.3% |
| FY2019 | $13.6M | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026